Using a 30-mL syringe and 18-gauge needle, reconstitute a vial of dry sterile trypticasesoy growth medium (vial 1) with 20 mL of sterile water for injection. Using a 60-mL syringe and 18-gauge ...

The biosimilar will be available in both subcutaneous and intravenous formulations and has nearly all the same indications as ...

The two products, both manufactured by Amgen, are aflibercept biosimilars Pavblu and Skojoy. Both biosimilars are indicated ...

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention ...

First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers.On track for commercial launch in the U.S. in the ...

The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.

The U-500 strength of Humulin R comes in two forms: 20-mL vials that you’ll use with insulin syringes 3-mL disposable ... to give yourself Humulin R about 30 minutes before you eat.

Avtozma is supplied as a preservative-free solution in 20mg/mL single-dose vials (80mg/4mL, 200mg/10mL, 400mg/20mL) for intravenous infusion, as well as in a single-dose prefilled syringe (162mg/0 ...

Omvoh has additional ongoing trials in Crohn's disease and UC, including studies to evaluate the long-term efficacy and safety of Omvoh in pediatric patients and adults, and a Phase 4 real-world ...